Researchers have detected novel biomarkers for kidney diseases associated with nephrotic syndrome using a new technique, a new study showed on Saturday. 

According to the study published in the New England Journal of Medicine, the researchers identified 'anti-nephrin autoantibodies' as a reliable biomarker for tracking disease progression, opening new roads for personalised treatment approaches.